Ftse Mib
34.378,84
1,49%
DAX
18.643,61
1,48%
S&P 500
5.442,70
1,25%
NASDAQ
17.664,64
1,85%
Bitcoin
69.786,23
3,65%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Structure Therapeutics Inc (GPCR) Structure Therapeutics Inc (GPCR) Notizie

GPCR

Structure Therapeutics (GPCR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GPCR
DataOraFonteTitoloSimboloCompagnia
07/06/202422:05GlobeNewswire Inc.Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary SharesNASDAQ:GPCRStructure Therapeutics Inc
06/06/202422:17Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:GPCRStructure Therapeutics Inc
06/06/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GPCRStructure Therapeutics Inc
06/06/202401:53GlobeNewswire Inc.Structure Therapeutics Announces Pricing of Upsized $476 Million Public OfferingNASDAQ:GPCRStructure Therapeutics Inc
06/06/202401:43Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:GPCRStructure Therapeutics Inc
06/06/202401:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GPCRStructure Therapeutics Inc
03/06/202422:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GPCRStructure Therapeutics Inc
03/06/202422:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GPCRStructure Therapeutics Inc
03/06/202422:09GlobeNewswire Inc.Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded WarrantsNASDAQ:GPCRStructure Therapeutics Inc
03/06/202422:02Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GPCRStructure Therapeutics Inc
03/06/202413:30GlobeNewswire Inc.Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290NASDAQ:GPCRStructure Therapeutics Inc
09/05/202422:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GPCRStructure Therapeutics Inc
09/05/202422:05GlobeNewswire Inc.Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
08/03/202422:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GPCRStructure Therapeutics Inc
08/03/202422:05GlobeNewswire Inc.Structure Therapeutics to Present at Leerink Partners Global Biopharma ConferenceNASDAQ:GPCRStructure Therapeutics Inc
08/03/202415:19Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GPCRStructure Therapeutics Inc
08/03/202414:30GlobeNewswire Inc.Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
18/12/202313:30GlobeNewswire Inc.Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical StudyNASDAQ:GPCRStructure Therapeutics Inc
17/11/202322:51Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:GPCRStructure Therapeutics Inc
14/11/202322:10GlobeNewswire Inc.Structure Therapeutics Reports Third Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
29/09/202313:32GlobeNewswire Inc.Structure Therapeutics Announces $300 Million Private Placement Equity FinancingNASDAQ:GPCRStructure Therapeutics Inc
29/09/202313:30GlobeNewswire Inc.Structure Therapeutics Announces Positive Results from Phase 1b Clinical Study of Oral GLP-1 Receptor Agonist GSBR-1290 and Provides Program UpdateNASDAQ:GPCRStructure Therapeutics Inc
10/08/202322:05GlobeNewswire Inc.Structure Therapeutics Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:GPCRStructure Therapeutics Inc
03/08/202323:32GlobeNewswire Inc.Structure Therapeutics Appoints Ted W. Love, M.D., to Board of DirectorsNASDAQ:GPCRStructure Therapeutics Inc
07/06/202314:30GlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations of its Oral GLP-1 Receptor Agonist GSBR-1290 at the American Diabetes Association 83rd Scientific SessionsNASDAQ:GPCRStructure Therapeutics Inc
05/06/202322:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GPCRStructure Therapeutics Inc
31/05/202322:30GlobeNewswire Inc.Structure Therapeutics to Present at Jefferies Healthcare ConferenceNASDAQ:GPCRStructure Therapeutics Inc
25/05/202322:30GlobeNewswire Inc.Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and ObesityNASDAQ:GPCRStructure Therapeutics Inc
18/05/202322:30GlobeNewswire Inc.Structure Therapeutics Announces Poster Presentations at the American Thoracic Society International ConferenceNASDAQ:GPCRStructure Therapeutics Inc
11/05/202323:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GPCRStructure Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GPCR

La tua Cronologia

COIN
EMC2ETH
Einsteinium
BOV
BRFSF190
BRFSF190 Ex:19
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network